Sai Life Sciences has scheduled its 27th Annual General Meeting for September 17, 2026. The meeting will be conducted through Video Conferencing or Other Audio-Visual Means in compliance with SEBI and MCA circulars.

The company dispatched the Integrated Annual Report for FY26 to members with registered email addresses on August 25, 2026. Shareholders without registered emails received a letter containing a weblink to access the report and AGM notice. Newspaper advertisements confirming the dispatch were published on August 26, 2026, in Financial Express and Mana Telangana.

Agenda Items

The primary agenda for the meeting includes:

• Receiving, considering, and adopting the Audited Standalone and Consolidated Financial Statements for the year ended March 31, 2026.
• Appointing Mr. Krishnamraju Kanumuri as a director in place of his retirement by rotation. He is eligible and offers himself for re-appointment.

Mr. Kanumuri serves as the Managing Director and CEO. He received remuneration of ₹ 13,07,65,004 in FY 2025-26. He holds a bachelor's degree in chemical engineering from Mangalore University and an MBA in Finance from the University of Kansas, USA.

E-Voting Schedule

Members can exercise voting rights electronically via KFin Technologies Limited. Voting rights are reckoned based on paid-up share value as of the cut-off date.

Meeting Details

The AGM will commence at 10:30 am on Thursday, September 17, 2026. Details regarding email registration, e-voting procedures, and VC/OAVM attendance are outlined in the AGM Notice. Members holding shares in physical mode may register email addresses with KFinTech at einward.ris@kfintech.com .

Runa Karan, Company Secretary & Compliance Officer (Membership No. A13721), signed the communication dated August 26, 2026.

Sai Life Sciences filed its Business Responsibility and Sustainability Report (BRSR) and ESG Databook for the financial year ended March 31, 2026, with stock exchanges on August 25, 2026. The disclosure, submitted pursuant to Regulation 34(2)(f) of the SEBI LODR Regulations, forms part of the company's Integrated Annual Report.

The filing covers standalone operations, including manufacturing sites in Hyderabad and Bidar, alongside R&D facilities in the UK. TUV India Private Limited provided reasonable assurance for the BRSR Core indicators and limited assurance for selected non-core disclosures under ISAE 3000 (Revised).

Environmental Performance

The ESG Databook outlines key environmental metrics for FY26 compared to the previous year. Total energy consumption rose to 3,85,999 GJ from 3,15,631 GJ in FY25. Renewable energy sources accounted for 1,77,993 GJ, while non-renewable sources contributed 2,08,006 GJ.

Greenhouse gas emissions data shows a divergence between direct and indirect emissions. Scope 1 emissions increased to 22,445 tCO2e from 18,435 tCO2e. Conversely, Scope 2 market-based emissions fell sharply to 8,630 tCO2e from 15,638 tCO2e, reflecting the company's renewable energy procurement strategy. Scope 3 emissions stood at 90,272 tCO2e.

Water withdrawal totalled 1,83,967.92 kilolitres, with groundwater comprising 1,02,390.35 kilolitres. The company reported implementing Zero Liquid Discharge systems at its Bidar manufacturing facility.

Workforce and Social Metrics

As of March 31, 2026, Sai Life Sciences employed 3,909 permanent employees and 1,315 workers. Female representation among permanent employees was 15.14%, while the board of directors included one female member (17%). The turnover rate for permanent employees decreased to 20.98% in FY26 from 24.17% in FY25.

The company reported zero fatalities and zero lost-time injury frequency rates for both employees and workers during the year. One complaint regarding sexual harassment was filed and resolved under the POSH Act.

Governance and Compliance

The report highlights adherence to various international standards, including ISO 14001 for environmental management and ISO 45001 for occupational health and safety across all Indian sites. The company disclosed no monetary penalties or fines related to regulatory non-compliance in FY26.